Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03813472 · ClinicalTrials.gov registry record
Hydration Sensor for Atopic Dermatitis
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 172
- Enrollment target
NCT03813472: Completed study, sponsored by Northwestern University.
NCT03813472 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 172 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03813472 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 172 participants
- Enrollment target
Study Summary
Pilot study of a soft, flexible hydration sensor
Primary Outcome
Percent agreement between experimental sensor and commercially available transepidermal water loss meter.
Interventions
- DEVICE Hydration Sensor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 172 participants |
| Start Date | 2019-11-25 |
| Est. Completion | 2023-02-28 |
What the finished NCT03813472 record still lists
NCT03813472 is an observational study that tracks outcomes without assigning an intervention. The registered 172 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Hydration Sensor is the first listed.
NCT03813472 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03813472 about?
NCT03813472 is a clinical study titled "Hydration Sensor for Atopic Dermatitis". Pilot study of a soft, flexible hydration sensor
What is the current status of trial NCT03813472?
This trial is currently completed. The enrollment target is 172 participants. The study started on 2019-11-25. Estimated completion is 2023-02-28.
What interventions are being tested in trial NCT03813472?
The interventions under investigation include: Hydration Sensor (DEVICE).
Who is sponsoring clinical trial NCT03813472?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04801797 · 172 participants · Phase 2
Venetoclax + Azacitidine vs. Induction Chemotherapy in AML
- NCT04867317 · 172 participants · Phase 3
Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)
- NCT05357040 · 172 participants · Phase 2
Antidepressant Effects of Nitrous Oxide
- NCT05587517 · 172 participants · Phase 2
A Clinical Trial of Interventions to Support Family Surrogates of Critically Ill Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI